{"id":"https://openalex.org/W4411908093","doi":"https://doi.org/10.1158/1078-0432.29444380","title":"Supplementary Table S1 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials","display_name":"Supplementary Table S1 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials","alternate_titles":[],"publication_year":2025,"publication_date":"2025-07-01","ids":{"openalex":"https://openalex.org/W4411908093","doi":"https://doi.org/10.1158/1078-0432.29444380"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.29444380","doi":"https://doi.org/10.1158/1078-0432.29444380","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444380","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4411908093"],"child_works_count":0,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.29444380","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080929197","display_name":"Kai Chen","orcid":"https://orcid.org/0000-0001-6773-4760","observed_orcids":["https://orcid.org/0000-0001-6773-4760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kai Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6773-4760","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084877136","display_name":"Ting-Yu Chen","orcid":"https://orcid.org/0000-0002-8525-0759","observed_orcids":["https://orcid.org/0000-0002-8525-0759"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ting-Yu Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8525-0759","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021900997","display_name":"Yiming Zhang","orcid":"https://orcid.org/0000-0002-1364-3051","observed_orcids":["https://orcid.org/0000-0002-1364-3051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiming Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1364-3051","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052092144","display_name":"Ruitao Lin","orcid":"https://orcid.org/0000-0003-2244-131X","observed_orcids":["https://orcid.org/0000-0003-2244-131X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruitao Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2244-131X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019360674","display_name":"Ying Yuan","orcid":"https://orcid.org/0000-0003-3163-480X","observed_orcids":["https://orcid.org/0000-0003-3163-480X","https://orcid.org/0009-0003-4406-2596"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Yuan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3163-480X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11798","display_name":"Optimal Experimental Design Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phase-i-oncology-trials","display_name":"phase I oncology trials","score":0.8460000157356262},{"id":"https://openalex.org/keywords/late-toxicity","display_name":"late toxicity","score":0.968999981880188},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6499999761581421},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C4577558","wikidata":"https://www.wikidata.org/wiki/Q384475","display_name":"Accrual","level":3,"score":0.8462045192718506},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.6368311643600464},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.5424078702926636},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.478278249502182},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.36913830041885376},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2674959897994995},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.24250665307044983},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.22155338525772095},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.18914476037025452},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10780301690101624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0949603021144867},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2781426361","wikidata":"https://www.wikidata.org/wiki/Q5326940","display_name":"Earnings","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.29444380","doi":"https://doi.org/10.1158/1078-0432.29444380","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444380","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/29444380","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Practical_Considerations_for_Using_the_TITE-BOIN_Design_to_Handle_Late-Onset_Toxicity_or_Fast_Accrual_in_Phase_I_Trials/29444380","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.29444380","doi":"https://doi.org/10.1158/1078-0432.29444380","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444380","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4411908069","https://openalex.org/W4361947430","https://openalex.org/W4410119637","https://openalex.org/W2804829033","https://openalex.org/W3046977721","https://openalex.org/W4366425149","https://openalex.org/W4361959961","https://openalex.org/W4210820575","https://openalex.org/W2912380993","https://openalex.org/W2737664341"],"abstract_inverted_index":{"Examples":[0],"of":[1],"phase":[2],"I":[3],"oncology":[4],"trials":[5],"registered":[6],"at":[7],"ClinicalTrial.gov":[8],"using":[9],"the":[10],"TITE-BOIN":[11],"design.":[12]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4411908093","counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-10-10T00:00:00"}
